Sepsismarker – was ist sinnvoll?

Schlüsselwörter

Sepsismarker - Anwendung - Procalcitonin - Interleukin-6 - C-reaktives Protein - Lipopolysaccarid-bindendes Protein

Keywords

sepsis marker - utility - procalcitonin - interleukin-6 - C-reactive protein - lipopolysaccarid-binding protein

Literatur

• 1 Bernard G R, Vincent J L, Laterre P F. et al . Efficacy and safety of recombinant human activated protein C for severe sepsis.  N Engl J Med. 2001;  344 699-709
• 2 Brunkhorst F M, Wegscheider K, Forycki Z F. et al . Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.  Intensive Care Med. 2000;  26 (Suppl) S148-52
• 3 Christ-Crain M, Jaccard-Stolz D, Bingisser R. et al . Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections.  Lancet. 2004;  363 600-7
• 4 Christ-Crain M, Jaccard-Stolz D, Bingisser R. et al . Procalcitonin-guidance of antibiotic therapy in community-acquired pneumonia.  Am J Respir Crit Care Med. 2006;  174 84-93
• 5 Christ-Crain M, Müller B. Procalcitonin in bacterial infections – hype, hope, more or less?.  Swiss Med Wkly. 2005;  135 451-460
• 6 Clec’h C, Fosse J -P, Karoubi P. et al . Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock.  Crit Care Med. 2006;  34 102-10
• 7 Dandona P, Nix D, Wilson M F. et al . Procalcitonin increase after endotoxin injection in normal subjects.  J Clin Endocrinol Metab. 1994;  79 1605-8
• 8 Engel C, Brunkhorst F M, Bone H G. et al . Epidemiology of sepsis in Germany.  Intensive Care Med. 2007;  33 606-18
• 9 Harbarth S, Holeckova K, Froidevaux C. et al . Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.  Am J Respir Crit Care Med. 2001;  164 396-402
• 10 Kumar A, Roberts D, Wood K E. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.  Crit Care Med. 2006;  34 (6) 1589-96
• 11 Levy M M, Fink M P, Marshall J C. et al . for the International Sepsis Definitions Conference, 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.  Intensive Care Med. 2003;  29 530-538
• 12 Meisner M. Procalcitonin. A new, innovative infection parameter. 3rd ed. Stuttgart; Georg Thieme Verlag 2000
• 13 Meisner M, Tschaikowsky K, Schnabel S. et al . Procalcitonin: Influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations.  Eur J Clin Chem Clin Biochem. 1997;  35 597-601
• 14 Müller B, Becker K L, Schächinger H. et al . Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit.  Crit Care Med. 2000;  28 977-83
• 15 Nobre V, Harbarth S, Graf J -D. et al . Use of procalcitonin to shorten antibiotic treatment duration in septic patients.   Am J Respir Crit Care Med. 2008;  177 498-505
• 16 Oberhoffer M, Karzai W, Meier-Hellmann A. et al . Sensitivity and specifity of various markers of inflammation for the prediction of tumor necrosis factor alpha and interleukin-6 in patients with sepsis.  Crit Care Med. 1999;  27 1814-18
• 17 Panacek E. et al . Neutralization of the TNF by a monoclonal antibody improves survival and reduces organ dysfunction in human sepsis.  Chest. 2000;  118 88S
• 18 Rangel-Frausto M S, Pittet D. et al . The natural history of the systemic inflammatory response syndrome (SIRS).  JAMA. 1995;  273 117-123
• 19 Reimer L G, Wilson M L, Weinstein M P. Update on detection of bacteremia and fungemia.  Clin Microbiol Rev. 1997;  10 444-465
• 20 Reinhart K, Brunkhorst F M, Bone H G. et al . Diagnosis and therapy of sepsis: Guidelines of the German Sepsis Society.  Internist. 2006;  47 356-73
• 21 Roder B L, Nielsen S L, Magnussen P, Engquist A. et al . Antibiotic usage in an intensive care unit in a Danish university hospital.  J Antimicrob Chemother. 1993;  32 633-42
• 22 Sakr Y, Burgett U, Nacul F E, Reinhart K, Brunkhorst F M. Lipopolysaccharide binding protein in a surgical ICU; a marker of sepsis?. Crit Care Med 2008 36: 2014-2022
• 23 Wakefield C H, Barclay G R, Fearon K C. et al . Proinflammatory mediator activity, endogenous antagonists and the systemic inflammatory response in intra-abdominal sepsis.   Brit J Surg. 1998;  85 818-825
• 24 Weinstein M P, Towns M L, Quartey S M. et al . The clinical significance of positive blood cultures in the 1990 s.  Clin Infect Dis. 1997;  24 584-602